Insider Transactions in Q4 2020 at Regulus Therapeutics Inc. (RGLS)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2020
|
Stelios Papadopoulos |
BUY
Grant, award, or other acquisition
|
Direct |
793,528
+28.54%
|
$0
$0.63 P/Share
|
|
Dec 04
2020
|
Joseph P Hagan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
39,680
+14.95%
|
$0
$0.63 P/Share
|
|
Dec 04
2020
|
Growth Equity Opportunities V, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Forest Baskett > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Ali Behbahani > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Carmen Chang > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Anthony A. Florence Jr. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Mohamad Makhzoumi > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Joshua Makower > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Scott D Sandell > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Peter W. Sonsini > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Dec 04
2020
|
Paul Edward Walker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,398,602
+40.54%
|
$0
$0.62 P/Share
|
|
Nov 16
2020
|
Joseph P Hagan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,094
-2.74%
|
$0
$0.52 P/Share
|
|
Nov 16
2020
|
Christopher Ray Aker Sr. VP & General Counsel |
SELL
Open market or private sale
|
Direct |
876
-3.29%
|
$0
$0.52 P/Share
|